BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:53:00 PM | Browse: 1510 | Download: 1641
 |
Received |
|
2013-02-03 13:28 |
 |
Peer-Review Started |
|
2013-02-04 21:49 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-03-20 10:27 |
 |
Revised |
|
2013-04-17 22:30 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-07-05 10:33 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-07-05 12:13 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-08-01 16:50 |
 |
Publish the Manuscript Online |
|
2013-08-27 16:46 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Autobiography |
| Article Title |
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mariarosa Tamè, Federica Buonfiglioli, Massimo Del Gaudio, Andrea Lisotti, Paolo Cecinato, Antonio Colecchia, Francesco Azzaroli, Antonietta D’Errico, Rosario Arena, Claudio Calvanese, Chiara Quarneti, Giorgio Ballardini, Antonio Daniele Pinna and Giuseppe Mazzella |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Federica Buonfiglioli, MD, Department of Digestive Diseases and Internal Medicine, S. Orsola-Malpighi Hospital, Via Massarenti, 9, 40138 Bologna, Italy. fedebuo82@yahoo.it |
| Key Words |
Hepatitis C virus; Hepatitis C recurrence; Interferon; Ribavirin; Liver transplantation |
| Core Tip |
Recurrent hepatitis C virus hepatitis is associated with a significant increase in morbidity and mortality of transplanted patients; biochemical and necro-inflammatory improves in transplanted patients who achieved a virological response after a course of antiviral treatment. Although the relative small sample size of our study, we demonstrated the efficacy of long-term antiviral treatment on disease progression despite the virological response, without significant side effects. |
| Publish Date |
2013-08-27 16:46 |
| Citation |
Tamè M, Buonfiglioli F, Del Gaudio M, Lisotti A, Cecinato P, Colecchia A, Azzaroli F, D’Errico A, Arena R, Calvanese C, Quarneti C, Ballardini G, Pinna AD, Mazzella G. Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. World J Gastroenterol 2013; 19(32): 5278-5285 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i32/5278.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i32.5278 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.